Can nicotine cause central sleep apnea?

Nicotine Does Not Cause Central Sleep Apnea

Based on the most recent and authoritative evidence, nicotine is not recognized as a cause of central sleep apnea (CSA). The 2025 American Academy of Sleep Medicine (AASM) clinical practice guideline on CSA treatment 1 provides a comprehensive classification of CSA etiologies and does not list nicotine or smoking as a causative factor.

CSA Classification and Recognized Causes

The AASM guideline 1 classifies CSA into 6 distinct categories:

• Primary CSA (idiopathic)
• CSA with Cheyne-Stokes respiration (typically heart failure-related)
• CSA due to medication or substance (specifically opioids, not nicotine)
• CSA due to medical disorder without Cheyne-Stokes
• Treatment-emergent CSA (develops during OSA treatment)
• CSA due to high altitude

Notably absent from this classification is any mention of nicotine or tobacco as a CSA etiology 1.

Nicotine's Actual Effects on Sleep and Breathing

Effects on Obstructive Sleep Apnea (OSA), Not CSA

The evidence consistently shows nicotine affects obstructive sleep apnea, not central apnea:

• Recent 2026 research 2, 3, 4, 5 demonstrates smoking is associated with worsened OSA severity and altered sleep architecture
• Nicotine primarily reduces REM sleep duration and N3 (deep slow-wave sleep) 5
• Historical studies 6, 7 actually suggested nicotine might reduce obstructive apneas by stimulating upper airway muscles, though this is not clinically recommended

Mechanism Clarification

The pathophysiology distinguishes these conditions 1:

• CSA results from absent or reduced respiratory effort due to ventilatory control instability, typically involving posthyperventilation hypocapnia
• OSA involves continued respiratory effort against an obstructed airway
• Nicotine's effects are primarily neuromuscular and inflammatory on the upper airway 8, not on central respiratory drive control

Important Clinical Caveat: Opioid-Associated CSA

The AASM guideline 1 specifically identifies opioids as causing CSA through unique pathways involving depressed central respiratory drive and decreased chemosensitivity. This is fundamentally different from nicotine's mechanism. While both are substances, they have entirely different effects on respiratory control:

• Opioids: Depress central respiratory drive → CSA
• Nicotine: Stimulates upper airway muscles and affects sleep architecture → OSA worsening and sleep fragmentation

Clinical Implications

If you encounter a patient with CSA who smokes:

1. Do not attribute the CSA to nicotine use - look for the actual underlying cause per AASM classification 1
2. Screen for opioid use if substance-related CSA is suspected
3. Address smoking separately as it worsens OSA, cardiovascular risk, and overall health 9
4. Optimize treatment for the true CSA etiology (heart failure, neurologic conditions, etc.) 1

The 2014 guideline on electronic cigarettes 9 extensively details nicotine's harmful effects on cardiovascular, neurologic, and metabolic systems, but does not mention CSA as a consequence.